Post-Rhinoplasty Taping Beneficial for Skin Envelope

This article originally appeared here.
Share this content:
Post-Rhinoplasty Taping Beneficial for Skin Envelope
Post-Rhinoplasty Taping Beneficial for Skin Envelope

FRIDAY, Feb. 26, 2016 (HealthDay News) -- Post-rhinoplasty taping (PRT) can help the skin envelope to compress and is particularly useful in thick-skinned patients, according to a study published online Feb. 25 in JAMA Facial Plastic Surgery.

Berke Ozucer, M.D., from the Gaziosmanpasa Taksim Research and Education Hospital in Istanbul, and colleagues examined the effect of PRT in 57 patients undergoing rhinoplasty who were randomized to a control group (20 patients) or to two- or four-week PRT groups (17 and 20 patients, respectively). Mean nasal skin thickness (MNST) was calculated and participants in each group were categorized according to MNST measurements as having thick skin or thin skin.

The researchers found that the four-week PRT group had a significant effect on the supratip compared with the control group (P = 0.001). Significant effects on MNST were seen for the two-week and four-week PRT groups compared with the control group (P = 0.02 and 0.007, respectively). A nonsignificant effect was seen on the tip (P = 0.052). In thin-skinned patients, PRT had no effect, while in thick-skinned patients, PRT had a significant effect on the MNST and the rhinion (P = 0.01 and 0.02, respectively), but not the tip or supratip (P = 0.06 and 0.07, respectively).

"The procedure can be used particularly in thick-skinned patients, in whom skin draping and nasal refinement is crucial to the surgical outcome," the authors write.

Abstract
Full Text
Editorial

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

WHO: Vaccine Hesitancy a Major Global Health Threat

WHO: Vaccine Hesitancy a Major Global Health Threat

Percentage of U.S. children 19 to 35 months who have not been vaccinated has quadrupled since 2001

FDA Down to 5 Weeks of Funding to Review New Drug Applications

FDA Down to 5 Weeks of Funding to ...

Agency cannot accept new fees or applications until the shutdown is over

FDA Approves First Generic Version of Epilepsy Drug Sabril

FDA Approves First Generic Version of Epilepsy Drug ...

Generic equivalents held to same vigorous manufacturing standards as brand-name drugs

is free, fast, and customized just for you!




Already a member?

Sign In Now »